ATRC Logo

AtriCure, Inc. (ATRC) 

NASDAQ
Market Cap
$1.76B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
286 of 968
Rank in Industry
17 of 49

Largest Insider Buys in Sector

ATRC Stock Price History Chart

ATRC Stock Performance

About AtriCure, Inc.

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Insider Activity of AtriCure, Inc.

Over the last 12 months, insiders at AtriCure, Inc. have bought $111,250 and sold $589,177 worth of AtriCure, Inc. stock.

On average, over the past 5 years, insiders at AtriCure, Inc. have bought $204,842 and sold $12.51M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Privitera Salvatore (Chief Technical Officer) — $111,250.

The last purchase of 5,000 shares for transaction amount of $111,250 was made by Privitera Salvatore (Chief Technical Officer) on 2024‑05‑30.

List of Insider Buy and Sell Transactions, AtriCure, Inc.

2024-08-15Saledirector
3,500
0.0082%
$24.07$84,2450.00%
2024-05-30PurchaseChief Technical Officer
5,000
0.0103%
$22.25$111,250+17.67%
2024-05-01SaleChief Mktg & Strategy Officer
1,500
0.003%
$24.09$36,135+2.02%
2024-04-01SaleChief Mktg & Strategy Officer
1,500
0.0033%
$30.39$45,585-15.19%
2024-03-18SaleChief Legal Officer
1,885
0.004%
$32.16$60,622-20.54%
2024-03-12SaleChief Mktg & Strategy Officer
1,500
0.0033%
$36.72$55,080-26.75%
2024-03-05SaleChief Legal Officer
8,231
0.0172%
$37.36$307,510-31.52%
2023-11-01SaleChief Legal Officer
1,248
0.0026%
$34.43$42,969-18.48%
2023-07-26SaleChief Legal Officer
3,417
0.008%
$57.09$195,077-40.50%
2023-06-08Saledirector
713
0.0015%
$47.89$34,146-25.66%
2023-06-06SaleChief Legal Officer
1,422
0.003%
$47.03$66,877-26.36%
2023-05-26Saledirector
4,313
0.0094%
$47.04$202,884-22.60%
2023-05-01SaleChief Legal Officer
4,417
0.0095%
$44.83$198,014-16.80%
2022-05-13SaleChief Human Resources Officer
3,203
0.007%
$42.69$136,736-0.84%
2022-04-08SaleChief Human Resources Officer
282
0.0006%
$61.59$17,368-30.04%
2022-03-04SaleChief Human Resources Officer
1,409
0.0031%
$67.66$95,333-35.60%
2022-03-02SaleChief Human Resources Officer
3,259
0.0071%
$70.40$229,434-38.89%
2022-02-11SaleChief Human Resources Officer
2,490
0.0057%
$67.97$169,245-32.51%
2022-01-14SaleChief Human Resources Officer
2,719
0.006%
$66.11$179,753-30.89%
2021-12-10SaleChief Human Resources Officer
1,528
0.0035%
$70.88$108,305-31.51%

Insider Historical Profitability

24.75%
Privitera SalvatoreChief Technical Officer
103290
0.2119%
$36.05111
Noznesky Justin JChief Mktg & Strategy Officer
71284
0.1462%
$36.05015
Dahlquist Karl S.Chief Legal Officer
50954
0.1045%
$36.0507
Yuen Maggiedirector
8970
0.0184%
$36.0502
Discovery Group I, LLC10 percent owner
1621334
3.3256%
$36.054725+15.37%
CARREL MICHAEL HPresident, CEO, & Director
504795
1.0354%
$36.05025
ROBARDS KAREN Pdirector
288328
0.5914%
$36.05233+76.77%
Wrubel Lee Rdirector
285717
0.586%
$36.05021
HARRISON DONALD Cdirector
198741
0.4076%
$36.0502
Drachman David JPresident and CEO
146000
0.2995%
$36.05415<0.0001%
Wade M. AndrewCFO
145120
0.2977%
$36.0509
Piton Julie AVP Fin & Admin & CFO
85922
0.1762%
$36.0512<0.0001%
Collar Mark Adirector
77307
0.1586%
$36.05210<0.0001%
Wirick Angela LChief Financial Officer
70146
0.1439%
$36.0502
LUX ANDREW LSVP, Ops & Quality
65589
0.1345%
$36.0512+17.91%
Seith Douglas JChief Operating Officer
64711
0.1327%
$36.05215+43.56%
Hooven Michael Ddirector
57049
0.117%
$36.0578<0.0001%
Lucky James LVP, Clinical, Regulatory & QS
51250
0.1051%
$36.05011
Drake Scott Williamdirector
41036
0.0842%
$36.0522+73.02%
JOHNSTON RICHARD Mdirector
34727
0.0712%
$36.05121+13.46%
Lanning Mark Rdirector
25000
0.0513%
$36.0530+43.44%
Preiss FrederickVice President Operations
24000
0.0492%
$36.0504
Krell Elizabeth Ddirector
19967
0.041%
$36.05112<0.0001%
Austin TonyaChief Human Resources Officer
17621
0.0361%
$36.05013
Doraiswamy VinayakChief Scientific Officer
16875
0.0346%
$36.0501
GROVES REGINA Edirector
16194
0.0332%
$36.0533+38.8%
Prange Karendirector
16140
0.0331%
$36.0501
WEHRWEIN SVENdirector
12686
0.026%
$36.0501
JOHNSON B KRISTINEdirector
10969
0.0225%
$36.0510+27.76%
PRESIDIO MANAGEMENT GROUP VIII L L C10 percent owner
9858
0.0202%
$36.0503
Walsh Richard SVice President; Sales
1750
0.0036%
$36.0520<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$144.59M9.824.75M-0.27%-$396,798.48<0.01
BlackRock$128.71M8.744.23M+0.89%+$1.13M<0.01
AllianceBernstein$111.12M7.553.65M+7.62%+$7.87M0.04
Champlain Investment Partners, LLC$81.56M5.542.68M+27.34%+$17.51M0.47
Fidelity Investments$75.36M5.122.48M+3,164.47%+$73.05M0.01
Wellington Management Company$49.89M3.391.64M+23.37%+$9.45M0.01
Macquarie Group$42.99M2.921.41M-2.52%-$1.11M0.04
First Light Asset Management$42.07M2.861.38M+2.48%+$1.02M3.54
Nuveen$41.79M2.841.37M+34.35%+$10.68M0.01
State Street$36.1M2.451.19M-1.47%-$539,711.65<0.01
Geode Capital Management$32.28M2.191.06M+2.74%+$861,474.14<0.01
Credit Suisse$29.96M2.04984,959-0.55%-$164,937.240.03
Dimensional Fund Advisors$29.82M2.03980,439-2.07%-$630,363.230.01
Morgan Stanley$29.5M2.01969,893+96.03%+$14.45M<0.01
Marshall Wace$29.24M1.99961,359+120.79%+$16M0.03
Fiera Capital$27.61M1.88907,775+2.94%+$789,368.570.08
TimesSquare Capital Management LLC$26M1.77854,547-12.45%-$3.7M0.38
Loomis, Sayles & Company$24.59M1.67808,425-3.08%-$781,968.720.04
GW&K Investment Management$24.31M1.65799,070-0.75%-$183,708.580.21
Neuberger Berman$23.96M1.63787,973+3.79%+$874,257.980.02
Wasatch Advisors$21.92M1.49720,677+38.62%+$6.11M0.12
Bank of America$18.36M1.25603,573+66.83%+$7.35M<0.01
Alger$16.99M1.15558,570-51.6%-$18.11M0.09
JPMorgan Chase$14.33M0.97471,012+32.22%+$3.49M<0.01
Northern Trust$13.9M0.94456,818-1.79%-$253,824.47<0.01
Emerald Advisers, Inc.$13.73M0.93451,258+1.11%+$151,430.760.56
Bellevue Group$13.61M0.93447,376-45.3%-$11.27M0.21
Assenagon Asset Management S.A.$13.53M0.92444,801+71.63%+$5.65M0.03
Goldman Sachs$12.27M0.83403,400+13.44%+$1.45M<0.01
Charles Schwab$11.43M0.78375,841+2.37%+$264,349.79<0.01
Millennium Management LLC$10.94M0.74359,742-18.46%-$2.48M0.01
Grandeur Peak Global Advisors, LLC$10.5M0.71345,030+49.01%+$3.45M0.84
Citadel Advisors LLC$9.35M0.64307,317+0.48%+$44,656.560.01
BNY Mellon$9.31M0.63305,984+23.03%+$1.74M<0.01
Deutsche Bank$9.17M0.62301,525+106.98%+$4.74M<0.01
Natixis$9.13M0.62300,000New+$9.13M0.05
Panagora$8.7M0.59286,111+24.83%+$1.73M0.04
EMERALD MUTUAL FUND ADVISERS TRUST$8.27M0.56271,814-24.99%-$2.75M0.43
DAFNA Capital Management, LLC$8.24M0.56271,029+115.91%+$4.43M0.2
Ubs Asset Management Americas Inc$8.16M0.55268,094+1.93%+$154,503.17<0.01
Amundi$6.1M0.54260,993-12.68%-$886,340.62<0.01
New York State Common Retirement Fund$7.84M0.53257,889<0.01%-$365.040.01
Kennedy Capital Management Inc$6.91M0.47227,193+115.47%+$3.7M0.15
Two Sigma$6.88M0.47226,179+17.35%+$1.02M0.01
WCM Investment Management$6.78M0.46222,843+0.64%+$43,409.340.02
Qube Research & Technologies$6.52M0.44214,232-4.96%-$340,338.940.01
Voloridge Investment Management, LLC$6.41M0.44210,647+31.57%+$1.54M0.02
State of Wisconsin Investment Board$6.29M0.43206,790-10.8%-$762,021.020.02
Two Sigma Advisers LP$5.81M0.4191,000+4.71%+$261,612.000.01
Silvercrest Asset Management Group Inc$5.8M0.39190,550-26.11%-$2.05M0.04
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.